Why the study?
Clinical trials evaluating vagus nerve stimulation in heart failure have yielded conflicting results, likely due to limited understanding of optimal stimulation parameters.
Transcutaneous vagus nerve stimulation is emerging as a promising noninvasive therapeutic modality for cardiac arrhythmias, though optimal stimulation parameters require further definition.
Parameter optimization may enhance VNS efficacy in arrhythmias; leaves open clinical translation pending targeted trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
A 2020 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: